Condensed Consolidated Balance Sheets - USD ($)		Apr. 30, 2022	Jan. 31, 2022
ASSETS
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accrued liabilities and other payable		20,933	4,270
Amount due to a director		24,499	24,499
TOTAL LIABILITIES		45,432	28,769
STOCKHOLDERS’ DEFICIT
Preferred stock, $0.001 par value, 20,000,000 shares authorized, 10,000,000 shares issued and outstanding, April 30, 2022   and January 31, 2022, respectively		10,000	10,000
Common stock, $0.001 par value, 103,103 shares authorized, 103,103 shares issued and outstanding as of April 30, 2022   and January 31, 2022, respectively	[1]	103	103
Additional paid-in capital		19,616,948	19,616,948
Accumulated deficit		(19,672,483)	(19,655,820)
TOTAL STOCKHOLDERS’ DEFICIT		(45,432)	(28,769)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

[1] Given effect of the Reverse Stock Split, See Note 6